Why is By-health Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.34% and Operating profit at -14.45% over the last 5 years
2
The company has declared Positive results for the last 3 consecutive quarters
- NET PROFIT(9M) At CNY 401.27 MM has Grown at 89.31%
- RAW MATERIAL COST(Y) Fallen by -4.8% (YoY)
- CASH AND EQV(HY) Highest at CNY 12,265.47 MM
3
With ROE of 5.95%, it has a attractive valuation with a 0.92 Price to Book Value
- Over the past year, while the stock has generated a return of -17.98%, its profits have risen by 87.4% ; the PEG ratio of the company is 0.2
- At the current price, the company has a high dividend yield of 7.2
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -17.98% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to By-health Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is By-health Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
By-health Co., Ltd.
-19.28%
-1.59
23.04%
China Shanghai Composite
3.0%
1.20
14.07%
Quality key factors
Factor
Value
Sales Growth (5y)
-1.34%
EBIT Growth (5y)
-14.45%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
0.56
Tax Ratio
19.81%
Dividend Payout Ratio
96.38%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
19.75%
ROE (avg)
14.00%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
1.36
EV to EBIT
14.21
EV to EBITDA
11.04
EV to Capital Employed
1.62
EV to Sales
1.69
PEG Ratio
0.26
Dividend Yield
4.90%
ROCE (Latest)
11.44%
ROE (Latest)
5.95%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -5.11% (YoY
CASH AND EQV(HY)
Highest at CNY 11,945.79 MM
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 897.76 MM
PRE-TAX PROFIT(Q)
Fallen at -27.04%
NET PROFIT(Q)
Fallen at -27.69%
Here's what is working for By-health Co., Ltd.
Cash and Eqv
Highest at CNY 11,945.79 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -5.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for By-health Co., Ltd.
Operating Cash Flow
Lowest at CNY 897.76 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Pre-Tax Profit
Fallen at -27.04%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Fallen at -27.69%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Footer loading






